Thick filament proteins and performance in human heart failure

Area of Science:

• Cardiology
• Molecular Biology
• Biochemistry

Background:

• Heart failure involves impaired myocardial contraction and relaxation.
• Thick filament proteins, particularly myosin heavy and light chains, are crucial for cardiac function.
• Alterations in these proteins are implicated in the pathophysiology of heart failure.

Purpose of the Study:

• To review the role of thick filament protein modifications in human heart failure.
• To elucidate how changes in myosin heavy chain (MHC) and myosin essential light chain (ELC) isoforms affect myocardial performance.
• To understand the impact of altered protein phosphorylation on cardiac function.

Main Methods:

• Review of existing literature on thick filament protein content and function in heart failure.
• Analysis of changes in alpha-myosin heavy chain (MHC) and beta-myosin heavy chain (MHC) isoforms.
• Examination of myosin essential light chain (ELC) isoform shifts (atrial vs. ventricular).
• Investigation of altered phosphorylation of myosin regulatory light chain and troponin-I.

Main Results:

• Reduced alpha-myosin heavy chain (MHC) content (<2% in failing vs. 5-10% in normal myocardium) is associated with slower actomyosin kinetics.
• Increased atrial myosin essential light chain (ELC) (up to 25%) in failing ventricles may compensate by promoting shortening velocity.
• Decreased phosphorylation of myosin regulatory light chain and troponin-I leads to increased myofilament calcium sensitivity, inhibiting relaxation.

Conclusions:

• Modifications in thick filament proteins, including MHC and ELC isoforms and phosphorylation status, directly impact myocardial mechanical output and relaxation.
• Reduced alpha-MHC and altered ELC contribute to impaired contractility and relaxation in heart failure.
• These protein changes are key determinants of cardiac dysfunction in heart failure, with some acting as compensatory mechanisms.